Skip to main navigation Skip to search Skip to main content

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

  • Naomi N. Hunder
  • , Herschel Wallen
  • , Jianhong Cao
  • , Deborah W. Hendricks
  • , John Z. Reilly
  • , Rebecca Rodmyre
  • , Achim Jungbluth
  • , Sacha Gnjatic
  • , John A. Thompson
  • , Cassian Yee

Research output: Contribution to journalArticlepeer-review

806 Scopus citations

Abstract

We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma-associated antigen NY-ESO-1. We infused these cells into a patient with refractory metastatic melanoma who had not undergone any previous conditioning or cytokine treatment. We show that the transferred CD4+ T cells mediated a durable clinical remission and led to endogenous responses against melanoma antigens other than NY-ESO-1.

Original languageEnglish
Pages (from-to)2698-2703
Number of pages6
JournalNew England Journal of Medicine
Volume358
Issue number25
DOIs
StatePublished - 19 Jun 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1'. Together they form a unique fingerprint.

Cite this